15 Hrs
المصدر:
Fox News
Fox News
جاهز للتشغيل
جاهز للتشغيل
The article discusses the rising interest among women in testosterone therapy for menopause-related symptoms such as low sexual desire, fatigue, and reduced quality of life. Currently, no FDA-approved testosterone products exist specifically for women, leading doctors to rely on off-label prescribing, compounded creams, or male gels, which pose regulatory and insurance challenges. A recent FDA workshop aims to evaluate the safety, evidence, and regulatory framework for female testosterone therapy, with experts advocating for standardized access and clearer guidelines.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading